CD7-CAR-T Cells Therapy

N/A

Report date: 2025/11/26 20:00:44

Base Information

Drug NameCD7-CAR-T Cells Therapy

Drug Alias NameAnti-CD7 Chimeric Antigen Receptor-Expressing T Cells TherapyCD7-CART01

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsAnti-CD7

TargetsT-cell antigen CD7

Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBambino Gesu Hospital And Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesBambino Gesu Hospital And Research Institute

Inactive CompaniesN/A

Active IndicationsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A